Wenqun H. Li

No. 172 Tongzipo Road
Changsha, 410078, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

CGRP mitigates myocardial ischemia-reperfusion injury by attenuating ferroptosis through the inhibition of MAMs and mitochondrial division.

CGRP mitigates myocardial ischemia-reperfusion injury by attenuating ferroptosis through the inhibition of MAMs and mitochondrial division.

Journal: International immunopharmacology

Published: December 20, 2025

Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases.

Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases.

Journal: Chemical biology & drug design

Published: September 11, 2025

Research progress of intestinal-hepatic axis in primary biliary cholangitis

Research progress of intestinal-hepatic axis in primary biliary cholangitis

Journal: Zhonghua nei ke za zhi

Published: June 08, 2025

Platelet membrane-fused and cardiac homing peptide-modified liposomes deliver puerarin to attenuate myocardial ischemia/reperfusion injury by inhibiting pyroptosis.

Platelet membrane-fused and cardiac homing peptide-modified liposomes deliver puerarin to attenuate myocardial ischemia/reperfusion injury by inhibiting pyroptosis.

Journal: Colloids and surfaces. B, Biointerfaces

Published: May 27, 2025

Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity.

Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity.

Journal: Cardiovascular drugs and therapy

Published: December 17, 2024

Xinmailong injection ameliorates Doxorubicin‑induced cardiotoxicity via the MDH2/OAA pathway.

Xinmailong injection ameliorates Doxorubicin‑induced cardiotoxicity via the MDH2/OAA pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 14, 2024

Mitigating Doxorubicin-Induced Cardiotoxicity and Enhancing Anti-Tumor Efficacy with a Metformin-Integrated Self-Assembled Nanomedicine.

Mitigating Doxorubicin-Induced Cardiotoxicity and Enhancing Anti-Tumor Efficacy with a Metformin-Integrated Self-Assembled Nanomedicine.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 19, 2024

Cardiac-targeted and ROS-responsive liposomes containing puerarin for attenuating myocardial ischemia-reperfusion injury.

Cardiac-targeted and ROS-responsive liposomes containing puerarin for attenuating myocardial ischemia-reperfusion injury.

Journal: Nanomedicine (London, England)

Published: September 24, 2024

Oridonin Alleviates Doxorubicin-Induced Cardiotoxicity by Inhibiting p38 MAPK/MMP3 Signaling Pathway.

Oridonin Alleviates Doxorubicin-Induced Cardiotoxicity by Inhibiting p38 MAPK/MMP3 Signaling Pathway.

Journal: Chemical biology & drug design

Published: September 15, 2024

Role for the F-box proteins in heart diseases.

Role for the F-box proteins in heart diseases.

Journal: Pharmacological research

Published: August 26, 2024

Puerarin-Loaded Liposomes Co-Modified by Ischemic Myocardium-Targeting Peptide and Triphenylphosphonium Cations Ameliorate Myocardial Ischemia-Reperfusion Injury.

Puerarin-Loaded Liposomes Co-Modified by Ischemic Myocardium-Targeting Peptide and Triphenylphosphonium Cations Ameliorate Myocardial Ischemia-Reperfusion Injury.

Journal: International journal of nanomedicine

Published: May 07, 2024

An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity.

An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity.

Journal: Cardiovascular drugs and therapy

Published: January 16, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026